Hi, what are you looking for?
Jewish Business News
Search results for "Teva Pharmaceutical"
Business
The exercising of the underwriters' options brings the total raised by Teva Pharmaceuticals in its current offering to $7.24 billion.
Business
Teva Pharmaceutical Industries Ltd has announced today two offerings totaling approximately $6.75 billion of ordinary and preferred shares to fund its takeover of Allergan Plc’s...
Life science
Pfizer will hold a 10% stake in the Israeli company, as part of its acquisition of Allergan.
Business
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) announced today that the the Japanese Ministry of Health, Labour and Welfare has approved once-daily...
Business
Gecko has developed a cloud-based solution to simplify chronic respiratory disease management through remote monitoring.
Business
The acquisition gives Teva exclusive rights to Immuneering's cutting-edge analytics to advance treatments for diseases of the CNS.
Business
Teva CFO Eyal Desheh: We appreciate the strong support we received which stems from the compelling economics of this transaction
Business
Teva bought its 4.6% stake in Mylan at prices of $69-74 per share. the share price is down sharply in premarket trading.
Business
The deal, the largest ever acquisition by an Israeli company, is in cash and shares.
Mergers & Acquisitions
Teva will pay over $45 billion for the botox maker unit, report the "Wall Street Journal."